0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and India Point-Of-Care Or Rapid Diagnostics Market Report & Forecast 2023-2029
Published Date: December 2023
|
Report Code: QYRE-Auto-2B16190
Home | Market Reports | Health| Medical Devices & Equipment
Global and India Point Of Care Or Rapid Diagnostics Market Report Forecast 2023 2029
BUY CHAPTERS

Global and India Point-Of-Care Or Rapid Diagnostics Market Report & Forecast 2023-2029

Code: QYRE-Auto-2B16190
Report
December 2023
Pages:125
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

and India Point-Of-Care Or Rapid Diagnostics Market Size

The global Point-Of-Care Or Rapid Diagnostics revenue was US$ 25670 million in 2022 and is forecast to a readjusted size of US$ 48500 million by 2029 with a CAGR of 9.4% during the forecast period (2023-2029).

and India Point-Of-Care Or Rapid Diagnostics Market

and India Point-Of-Care Or Rapid Diagnostics Market

Point-of-care testing (POCT or bedside testing) is defined as medical diagnostic testing at or near the point of care—that is, at the time and place of patient care.
In our report, blood glucose test strips and blood glucose meter, which mainly used at home, are not included.
In India, the Point-Of-Care Or Rapid Diagnostics revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2023-2029).
In Spain & Portugal Market, Oint-of-Care or Rapid Diagnostics key players include, Roche, Abbott, Danaher, Siemens Healthcare, Bio-Rad Laboratories, etc. Top 5 manufacturers hold a share over 74%.
In terms of product, Intensive Care is the largest segment, with a share over 19%. And in terms of application, the largest application is Hospital, followed by Clinic, Independent Laboratories and Others.
This report focuses on global and India Point-Of-Care Or Rapid Diagnostics market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Point-Of-Care Or Rapid Diagnostics will continue to grow rapidly in the future.
Global Point-Of-Care Or Rapid Diagnostics Scope and Market Size
Point-Of-Care Or Rapid Diagnostics market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Point-Of-Care Or Rapid Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.
For India market, this report focuses on the Point-Of-Care Or Rapid Diagnostics market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Point-Of-Care Or Rapid Diagnostics Market Report

Report Metric Details
Report Name and India Point-Of-Care Or Rapid Diagnostics Market
Forecasted market size in 2029 US$ 48500 million
CAGR 9.4%
Forecasted years 2023 - 2029
Segment by Type
  • Intensive Care
  • Covid-19 Testing
  • Infectious Diseases Testing
  • Cardiac Markers Testing
  • Coagulation Testing
  • Others
Segment by Application
  • Hospital
  • Clinic
  • Independent Laboratories
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche, Abbott, Danaher, Siemens Healthcare, Bio-Rad Laboratories, BioMerieux, Nova Biomedical, Thermo Fisher Scientific, Quidel, A. Menarini Diagnostics, Becton Dickinson, Biosurfit, Astrego Diagnostics, Werfen, Abionic, Palex Medical/Bülhmann, Horiba Medical, RAL, Vircell, Monlab, Binding Site
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India Point-Of-Care Or Rapid Diagnostics Market size in 2029?

Ans: The and India Point-Of-Care Or Rapid Diagnostics Market size in 2029 will be US$ 48500 million.

What is the market share of major companies in and India Point-Of-Care Or Rapid Diagnostics Market?

Ans: Top 5 manufacturers hold a share over 74%.

What is the and India Point-Of-Care Or Rapid Diagnostics Market share by type?

Ans: In terms of product, Intensive Care is the largest segment, with a share over 19%.

What is the and India Point-Of-Care Or Rapid Diagnostics Market share by region?

Ans: According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

Who are the main players in the and India Point-Of-Care Or Rapid Diagnostics Market report?

Ans: The main players in the and India Point-Of-Care Or Rapid Diagnostics Market are Roche, Abbott, Danaher, Siemens Healthcare, Bio-Rad Laboratories, BioMerieux, Nova Biomedical, Thermo Fisher Scientific, Quidel, A. Menarini Diagnostics, Becton Dickinson, Biosurfit, Astrego Diagnostics, Werfen, Abionic, Palex Medical/Bülhmann, Horiba Medical, RAL, Vircell, Monlab, Binding Site

What are the Application segmentation covered in the and India Point-Of-Care Or Rapid Diagnostics Market report?

Ans: The Applications covered in the and India Point-Of-Care Or Rapid Diagnostics Market report are Hospital, Clinic, Independent Laboratories, Others

What are the Type segmentation covered in the and India Point-Of-Care Or Rapid Diagnostics Market report?

Ans: The Types covered in the and India Point-Of-Care Or Rapid Diagnostics Market report are Intensive Care, Covid-19 Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Others

1 Study Coverage
1.1 Point-Of-Care Or Rapid Diagnostics Product Introduction
1.2 Global Point-Of-Care Or Rapid Diagnostics Outlook 2018 VS 2022 VS 2029
1.2.1 Global Point-Of-Care Or Rapid Diagnostics Sales in US$ Million for the Year 2018-2029
1.2.2 Global Point-Of-Care Or Rapid Diagnostics Sales in Volume for the Year 2018-2029
1.3 India Point-Of-Care Or Rapid Diagnostics Outlook 2018 VS 2022 VS 2029
1.3.1 India Point-Of-Care Or Rapid Diagnostics Sales in US$ Million for the Year 2018-2029
1.3.2 India Point-Of-Care Or Rapid Diagnostics Sales in Volume for the Year 2018-2029
1.4 Point-Of-Care Or Rapid Diagnostics Market Size, India VS Global, 2018 VS 2022 VS 2029
1.4.1 The Market Share of India Point-Of-Care Or Rapid Diagnostics in Global, 2018 VS 2022 VS 2029
1.4.2 The Growth Rate of Point-Of-Care Or Rapid Diagnostics Market Size, India VS Global, 2018 VS 2022 VS 2029
1.5 Point-Of-Care Or Rapid Diagnostics Market Dynamics
1.5.1 Point-Of-Care Or Rapid Diagnostics Industry Trends
1.5.2 Point-Of-Care Or Rapid Diagnostics Market Drivers
1.5.3 Point-Of-Care Or Rapid Diagnostics Market Challenges
1.5.4 Point-Of-Care Or Rapid Diagnostics Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Point-Of-Care Or Rapid Diagnostics by Type
2.1 Point-Of-Care Or Rapid Diagnostics Market Segment by Type
2.1.1 Intensive Care
2.1.2 Covid-19 Testing
2.1.3 Infectious Diseases Testing
2.1.4 Cardiac Markers Testing
2.1.5 Coagulation Testing
2.1.6 Others
2.2 Global Point-Of-Care Or Rapid Diagnostics Market Size by Type
2.2.1 Global Point-Of-Care Or Rapid Diagnostics Sales in Value, by Type (2018, 2022 & 2029)
2.2.2 Global Point-Of-Care Or Rapid Diagnostics Sales in Volume, by Type (2018, 2022 & 2029)
2.2.3 Global Point-Of-Care Or Rapid Diagnostics Average Selling Price (ASP) by Type (2018, 2022 & 2029)
2.3 India Point-Of-Care Or Rapid Diagnostics Market Size by Type
2.3.1 India Point-Of-Care Or Rapid Diagnostics Sales in Value, by Type (2018, 2022 & 2029)
2.3.2 India Point-Of-Care Or Rapid Diagnostics Sales in Volume, by Type (2018, 2022 & 2029)
2.3.3 India Point-Of-Care Or Rapid Diagnostics Average Selling Price (ASP) by Type (2018, 2022 & 2029)
3 Point-Of-Care Or Rapid Diagnostics by Application
3.1 Point-Of-Care Or Rapid Diagnostics Market Segment by Application
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Independent Laboratories
3.1.4 Others
3.2 Global Point-Of-Care Or Rapid Diagnostics Market Size by Application
3.2.1 Global Point-Of-Care Or Rapid Diagnostics Sales in Value, by Application (2018, 2022 & 2029)
3.2.2 Global Point-Of-Care Or Rapid Diagnostics Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 Global Point-Of-Care Or Rapid Diagnostics Average Selling Price (ASP) by Application (2018, 2022 & 2029)
3.3 India Point-Of-Care Or Rapid Diagnostics Market Size by Application
3.3.1 India Point-Of-Care Or Rapid Diagnostics Sales in Value, by Application (2018, 2022 & 2029)
3.3.2 India Point-Of-Care Or Rapid Diagnostics Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 India Point-Of-Care Or Rapid Diagnostics Average Selling Price (ASP) by Application (2018, 2022 & 2029)
4 Global Point-Of-Care Or Rapid Diagnostics Competitor Landscape by Company
4.1 Global Point-Of-Care Or Rapid Diagnostics Market Size by Company
4.1.1 Global Key Manufacturers of Point-Of-Care Or Rapid Diagnostics, Ranked by Revenue (2022)
4.1.2 Global Point-Of-Care Or Rapid Diagnostics Revenue by Manufacturer (2018-2023)
4.1.3 Global Point-Of-Care Or Rapid Diagnostics Sales by Manufacturer (2018-2023)
4.1.4 Global Point-Of-Care Or Rapid Diagnostics Price by Manufacturer (2018-2023)
4.2 Global Point-Of-Care Or Rapid Diagnostics Concentration Ratio (CR)
4.2.1 Point-Of-Care Or Rapid Diagnostics Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Point-Of-Care Or Rapid Diagnostics in 2022
4.2.3 Global Point-Of-Care Or Rapid Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Point-Of-Care Or Rapid Diagnostics, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Point-Of-Care Or Rapid Diagnostics, Product Offered and Application
4.5 Global Key Manufacturers of Point-Of-Care Or Rapid Diagnostics, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 India Point-Of-Care Or Rapid Diagnostics Market Size by Company
4.7.1 Key Players of Point-Of-Care Or Rapid Diagnostics in India, Ranked by Revenue (2022)
4.7.2 India Point-Of-Care Or Rapid Diagnostics Revenue by Players (2018-2023)
4.7.3 India Point-Of-Care Or Rapid Diagnostics Sales by Players (2018-2023)
5 Global Point-Of-Care Or Rapid Diagnostics Market Size by Region
5.1 Global Point-Of-Care Or Rapid Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Point-Of-Care Or Rapid Diagnostics Market Size in Volume by Region (2018-2029)
5.2.1 Global Point-Of-Care Or Rapid Diagnostics Sales in Volume by Region: 2018-2023
5.2.2 Global Point-Of-Care Or Rapid Diagnostics Sales in Volume Forecast by Region (2024-2029)
5.3 Global Point-Of-Care Or Rapid Diagnostics Market Size in Value by Region (2018-2029)
5.3.1 Global Point-Of-Care Or Rapid Diagnostics Sales in Value by Region: 2018-2023
5.3.2 Global Point-Of-Care Or Rapid Diagnostics Sales in Value by Region: 2024-2029
6 Americas
6.1 Americas Point-Of-Care Or Rapid Diagnostics Market Size YoY Growth 2018-2029
6.2 Americas Point-Of-Care Or Rapid Diagnostics Sales in Volume, by Type (2018, 2022 & 2029)
6.3 Americas Point-Of-Care Or Rapid Diagnostics Sales in Volume, by Application (2018, 2022 & 2029)
6.4 Americas Point-Of-Care Or Rapid Diagnostics Market Facts & Figures by Country (2018, 2022 & 2029)
6.4.1 Americas Point-Of-Care Or Rapid Diagnostics Sales in Value by Country (2018, 2022 & 2029)
6.4.2 Americas Point-Of-Care Or Rapid Diagnostics Sales in Volume by Country (2018, 2022 & 2029)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Point-Of-Care Or Rapid Diagnostics Market Size YoY Growth 2018-2029
7.2 EMEA Point-Of-Care Or Rapid Diagnostics Sales in Volume, by Type (2018, 2022 & 2029)
7.3 EMEA Point-Of-Care Or Rapid Diagnostics Sales in Volume, by Application (2018, 2022 & 2029)
7.4 EMEA Point-Of-Care Or Rapid Diagnostics Market Facts & Figures by Country (2018, 2022 & 2029)
7.4.1 EMEA Point-Of-Care Or Rapid Diagnostics Sales in Value by Country (2018, 2022 & 2029)
7.4.2 EMEA Point-Of-Care Or Rapid Diagnostics Sales in Volume by Country (2018, 2022 & 2029)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Point-Of-Care Or Rapid Diagnostics Market Size YoY Growth 2018-2029
8.2 China Point-Of-Care Or Rapid Diagnostics Sales in Volume, by Type (2018, 2022 & 2029)
8.3 China Point-Of-Care Or Rapid Diagnostics Sales in Volume, by Application (2018, 2022 & 2029)
9 APAC
9.1 APAC Point-Of-Care Or Rapid Diagnostics Market Size YoY Growth 2018-2029
9.2 APAC Point-Of-Care Or Rapid Diagnostics Sales in Volume, by Type (2018, 2022 & 2029)
9.3 APAC Point-Of-Care Or Rapid Diagnostics Sales in Volume, by Application (2018, 2022 & 2029)
9.4 APAC Point-Of-Care Or Rapid Diagnostics Market Facts & Figures by Region (2018, 2022 & 2029)
9.4.1 APAC Point-Of-Care Or Rapid Diagnostics Sales in Value by Region (2018, 2022 & 2029)
9.4.2 APAC Point-Of-Care Or Rapid Diagnostics Sales in Volume by Region (2018, 2022 & 2029)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Roche
10.1.1 Roche Company Information
10.1.2 Roche Description and Business Overview
10.1.3 Roche Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Roche Point-Of-Care Or Rapid Diagnostics Products Offered
10.1.5 Roche Recent Development
10.2 Abbott
10.2.1 Abbott Company Information
10.2.2 Abbott Description and Business Overview
10.2.3 Abbott Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Abbott Point-Of-Care Or Rapid Diagnostics Products Offered
10.2.5 Abbott Recent Development
10.3 Danaher
10.3.1 Danaher Company Information
10.3.2 Danaher Description and Business Overview
10.3.3 Danaher Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Danaher Point-Of-Care Or Rapid Diagnostics Products Offered
10.3.5 Danaher Recent Development
10.4 Siemens Healthcare
10.4.1 Siemens Healthcare Company Information
10.4.2 Siemens Healthcare Description and Business Overview
10.4.3 Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Products Offered
10.4.5 Siemens Healthcare Recent Development
10.5 Bio-Rad Laboratories
10.5.1 Bio-Rad Laboratories Company Information
10.5.2 Bio-Rad Laboratories Description and Business Overview
10.5.3 Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Products Offered
10.5.5 Bio-Rad Laboratories Recent Development
10.6 BioMerieux
10.6.1 BioMerieux Company Information
10.6.2 BioMerieux Description and Business Overview
10.6.3 BioMerieux Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
10.6.4 BioMerieux Point-Of-Care Or Rapid Diagnostics Products Offered
10.6.5 BioMerieux Recent Development
10.7 Nova Biomedical
10.7.1 Nova Biomedical Company Information
10.7.2 Nova Biomedical Description and Business Overview
10.7.3 Nova Biomedical Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Nova Biomedical Point-Of-Care Or Rapid Diagnostics Products Offered
10.7.5 Nova Biomedical Recent Development
10.8 Thermo Fisher Scientific
10.8.1 Thermo Fisher Scientific Company Information
10.8.2 Thermo Fisher Scientific Description and Business Overview
10.8.3 Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Products Offered
10.8.5 Thermo Fisher Scientific Recent Development
10.9 Quidel
10.9.1 Quidel Company Information
10.9.2 Quidel Description and Business Overview
10.9.3 Quidel Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Quidel Point-Of-Care Or Rapid Diagnostics Products Offered
10.9.5 Quidel Recent Development
10.10 A. Menarini Diagnostics
10.10.1 A. Menarini Diagnostics Company Information
10.10.2 A. Menarini Diagnostics Description and Business Overview
10.10.3 A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
10.10.4 A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Products Offered
10.10.5 A. Menarini Diagnostics Recent Development
10.11 Becton Dickinson
10.11.1 Becton Dickinson Company Information
10.11.2 Becton Dickinson Description and Business Overview
10.11.3 Becton Dickinson Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Becton Dickinson Point-Of-Care Or Rapid Diagnostics Products Offered
10.11.5 Becton Dickinson Recent Development
10.12 Biosurfit
10.12.1 Biosurfit Company Information
10.12.2 Biosurfit Description and Business Overview
10.12.3 Biosurfit Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Biosurfit Point-Of-Care Or Rapid Diagnostics Products Offered
10.12.5 Biosurfit Recent Development
10.13 Astrego Diagnostics
10.13.1 Astrego Diagnostics Company Information
10.13.2 Astrego Diagnostics Description and Business Overview
10.13.3 Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Products Offered
10.13.5 Astrego Diagnostics Recent Development
10.14 Werfen
10.14.1 Werfen Company Information
10.14.2 Werfen Description and Business Overview
10.14.3 Werfen Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Werfen Point-Of-Care Or Rapid Diagnostics Products Offered
10.14.5 Werfen Recent Development
10.15 Abionic
10.15.1 Abionic Company Information
10.15.2 Abionic Description and Business Overview
10.15.3 Abionic Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Abionic Point-Of-Care Or Rapid Diagnostics Products Offered
10.15.5 Abionic Recent Development
10.16 Palex Medical/Bülhmann
10.16.1 Palex Medical/Bülhmann Company Information
10.16.2 Palex Medical/Bülhmann Description and Business Overview
10.16.3 Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Products Offered
10.16.5 Palex Medical/Bülhmann Recent Development
10.17 Horiba Medical
10.17.1 Horiba Medical Company Information
10.17.2 Horiba Medical Description and Business Overview
10.17.3 Horiba Medical Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Horiba Medical Point-Of-Care Or Rapid Diagnostics Products Offered
10.17.5 Horiba Medical Recent Development
10.18 RAL
10.18.1 RAL Company Information
10.18.2 RAL Description and Business Overview
10.18.3 RAL Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
10.18.4 RAL Point-Of-Care Or Rapid Diagnostics Products Offered
10.18.5 RAL Recent Development
10.19 Vircell
10.19.1 Vircell Company Information
10.19.2 Vircell Description and Business Overview
10.19.3 Vircell Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
10.19.4 Vircell Point-Of-Care Or Rapid Diagnostics Products Offered
10.19.5 Vircell Recent Development
10.20 Monlab
10.20.1 Monlab Company Information
10.20.2 Monlab Description and Business Overview
10.20.3 Monlab Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
10.20.4 Monlab Point-Of-Care Or Rapid Diagnostics Products Offered
10.20.5 Monlab Recent Development
10.21 Binding Site
10.21.1 Binding Site Company Information
10.21.2 Binding Site Description and Business Overview
10.21.3 Binding Site Point-Of-Care Or Rapid Diagnostics Sales, Revenue and Gross Margin (2018-2023)
10.21.4 Binding Site Point-Of-Care Or Rapid Diagnostics Products Offered
10.21.5 Binding Site Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Point-Of-Care Or Rapid Diagnostics Industry Chain Analysis
11.2 Point-Of-Care Or Rapid Diagnostics Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Point-Of-Care Or Rapid Diagnostics Production Mode & Process
11.4 Point-Of-Care Or Rapid Diagnostics Sales and Marketing
11.4.1 Point-Of-Care Or Rapid Diagnostics Sales Channels
11.4.2 Point-Of-Care Or Rapid Diagnostics Distributors
11.5 Point-Of-Care Or Rapid Diagnostics Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
    Table 1. Point-Of-Care Or Rapid Diagnostics CAGR in Value, India VS Global, 2018 VS 2022 VS 2029
    Table 2. Point-Of-Care Or Rapid Diagnostics Market Trends
    Table 3. Point-Of-Care Or Rapid Diagnostics Market Drivers
    Table 4. Point-Of-Care Or Rapid Diagnostics Market Challenges
    Table 5. Point-Of-Care Or Rapid Diagnostics Market Restraints
    Table 6. Global Point-Of-Care Or Rapid Diagnostics Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 7. India Point-Of-Care Or Rapid Diagnostics Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 8. Global Point-Of-Care Or Rapid Diagnostics Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 9. India Point-Of-Care Or Rapid Diagnostics Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 10. Global Key Manufacturers of Point-Of-Care Or Rapid Diagnostics, Ranked by Revenue (2022) & (US$ Million)
    Table 11. Global Point-Of-Care Or Rapid Diagnostics Revenue by Manufacturer, (US$ Million), 2018-2023
    Table 12. Global Point-Of-Care Or Rapid Diagnostics Revenue Share by Manufacturer, 2018-2023
    Table 13. Global Point-Of-Care Or Rapid Diagnostics Sales by Manufacturer, (K Doses), 2018-2023
    Table 14. Global Point-Of-Care Or Rapid Diagnostics Sales Share by Manufacturer, 2018-2023
    Table 15. Global Point-Of-Care Or Rapid Diagnostics Price by Manufacturer (2018-2023) & (US$/Dose)
    Table 16. Global Point-Of-Care Or Rapid Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Point-Of-Care Or Rapid Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-Of-Care Or Rapid Diagnostics as of 2022)
    Table 18. Global Key Manufacturers of Point-Of-Care Or Rapid Diagnostics, Manufacturing Base Distribution and Headquarters
    Table 19. Global Key Manufacturers of Point-Of-Care Or Rapid Diagnostics, Product Offered and Application
    Table 20. Global Key Manufacturers of Point-Of-Care Or Rapid Diagnostics, Date of Enter into This Industry
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Key Players of Point-Of-Care Or Rapid Diagnostics in India, Ranked by Revenue (2022) & (US$ million)
    Table 23. India Point-Of-Care Or Rapid Diagnostics Revenue by Players, (US$ Million), (2018-2023)
    Table 24. India Point-Of-Care Or Rapid Diagnostics Revenue Share by Players, (2018-2023)
    Table 25. India Point-Of-Care Or Rapid Diagnostics Sales by Players, (K Doses), (2018-2023)
    Table 26. India Point-Of-Care Or Rapid Diagnostics Sales Share by Players, (2018-2023)
    Table 27. Global Point-Of-Care Or Rapid Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 28. Global Point-Of-Care Or Rapid Diagnostics Sales in Volume by Region (2018-2023) & (K Doses)
    Table 29. Global Point-Of-Care Or Rapid Diagnostics Sales in Volume Forecast by Region (2024-2029) & (K Doses)
    Table 30. Global Point-Of-Care Or Rapid Diagnostics Sales in Value by Region (2018-2023) & (US$ Million)
    Table 31. Global Point-Of-Care Or Rapid Diagnostics Sales in Value Forecast by Region (2024-2029) & (US$ Million)
    Table 32. Americas Point-Of-Care Or Rapid Diagnostics Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 33. Americas Point-Of-Care Or Rapid Diagnostics Sales in Value by Country (2018-2023) & (US$ Million)
    Table 34. Americas Point-Of-Care Or Rapid Diagnostics Sales in Value by Country (2024-2029) & (US$ Million)
    Table 35. Americas Point-Of-Care Or Rapid Diagnostics Sales in Volume by Country (2018-2023) & (K Doses)
    Table 36. Americas Point-Of-Care Or Rapid Diagnostics Sales in Volume by Country (2024-2029) & (K Doses)
    Table 37. EMEA Point-Of-Care Or Rapid Diagnostics Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 38. EMEA Point-Of-Care Or Rapid Diagnostics Sales in Value by Country (2018-2023) & (US$ Million)
    Table 39. EMEA Point-Of-Care Or Rapid Diagnostics Sales in Value by Country (2024-2029) & (US$ Million)
    Table 40. EMEA Point-Of-Care Or Rapid Diagnostics Sales in Volume by Country (2018-2023) & (K Doses)
    Table 41. EMEA Point-Of-Care Or Rapid Diagnostics Sales in Volume by Country (2024-2029) & (K Doses)
    Table 42. APAC Point-Of-Care Or Rapid Diagnostics Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 43. APAC Point-Of-Care Or Rapid Diagnostics Sales in Value by Country (2018-2023) & (US$ Million)
    Table 44. APAC Point-Of-Care Or Rapid Diagnostics Sales in Value by Country (2024-2029) & (US$ Million)
    Table 45. APAC Point-Of-Care Or Rapid Diagnostics Sales in Volume by Country (2018-2023) & (K Doses)
    Table 46. APAC Point-Of-Care Or Rapid Diagnostics Sales in Volume by Country (2024-2029) & (K Doses)
    Table 47. Roche Company Information
    Table 48. Roche Description and Business Overview
    Table 49. Roche Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
    Table 50. Roche Point-Of-Care Or Rapid Diagnostics Product
    Table 51. Roche Recent Development
    Table 52. Abbott Company Information
    Table 53. Abbott Description and Business Overview
    Table 54. Abbott Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
    Table 55. Abbott Point-Of-Care Or Rapid Diagnostics Product
    Table 56. Abbott Recent Development
    Table 57. Danaher Company Information
    Table 58. Danaher Description and Business Overview
    Table 59. Danaher Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
    Table 60. Danaher Point-Of-Care Or Rapid Diagnostics Product
    Table 61. Danaher Recent Development
    Table 62. Siemens Healthcare Company Information
    Table 63. Siemens Healthcare Description and Business Overview
    Table 64. Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
    Table 65. Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Product
    Table 66. Siemens Healthcare Recent Development
    Table 67. Bio-Rad Laboratories Company Information
    Table 68. Bio-Rad Laboratories Description and Business Overview
    Table 69. Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
    Table 70. Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Product
    Table 71. Bio-Rad Laboratories Recent Development
    Table 72. BioMerieux Company Information
    Table 73. BioMerieux Description and Business Overview
    Table 74. BioMerieux Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
    Table 75. BioMerieux Point-Of-Care Or Rapid Diagnostics Product
    Table 76. BioMerieux Recent Development
    Table 77. Nova Biomedical Company Information
    Table 78. Nova Biomedical Description and Business Overview
    Table 79. Nova Biomedical Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
    Table 80. Nova Biomedical Point-Of-Care Or Rapid Diagnostics Product
    Table 81. Nova Biomedical Recent Development
    Table 82. Thermo Fisher Scientific Company Information
    Table 83. Thermo Fisher Scientific Description and Business Overview
    Table 84. Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
    Table 85. Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Product
    Table 86. Thermo Fisher Scientific Recent Development
    Table 87. Quidel Company Information
    Table 88. Quidel Description and Business Overview
    Table 89. Quidel Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
    Table 90. Quidel Point-Of-Care Or Rapid Diagnostics Product
    Table 91. Quidel Recent Development
    Table 92. A. Menarini Diagnostics Company Information
    Table 93. A. Menarini Diagnostics Description and Business Overview
    Table 94. A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
    Table 95. A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Product
    Table 96. A. Menarini Diagnostics Recent Development
    Table 97. Becton Dickinson Company Information
    Table 98. Becton Dickinson Description and Business Overview
    Table 99. Becton Dickinson Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
    Table 100. Becton Dickinson Point-Of-Care Or Rapid Diagnostics Product
    Table 101. Becton Dickinson Recent Development
    Table 102. Biosurfit Company Information
    Table 103. Biosurfit Description and Business Overview
    Table 104. Biosurfit Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
    Table 105. Biosurfit Point-Of-Care Or Rapid Diagnostics Product
    Table 106. Biosurfit Recent Development
    Table 107. Astrego Diagnostics Company Information
    Table 108. Astrego Diagnostics Description and Business Overview
    Table 109. Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
    Table 110. Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Product
    Table 111. Astrego Diagnostics Recent Development
    Table 112. Werfen Company Information
    Table 113. Werfen Description and Business Overview
    Table 114. Werfen Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
    Table 115. Werfen Point-Of-Care Or Rapid Diagnostics Product
    Table 116. Werfen Recent Development
    Table 117. Abionic Company Information
    Table 118. Abionic Description and Business Overview
    Table 119. Abionic Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
    Table 120. Abionic Point-Of-Care Or Rapid Diagnostics Product
    Table 121. Abionic Recent Development
    Table 122. Palex Medical/Bülhmann Company Information
    Table 123. Palex Medical/Bülhmann Description and Business Overview
    Table 124. Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
    Table 125. Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Product
    Table 126. Palex Medical/Bülhmann Recent Development
    Table 127. Horiba Medical Company Information
    Table 128. Horiba Medical Description and Business Overview
    Table 129. Horiba Medical Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
    Table 130. Horiba Medical Point-Of-Care Or Rapid Diagnostics Product
    Table 131. Horiba Medical Recent Development
    Table 132. RAL Company Information
    Table 133. RAL Description and Business Overview
    Table 134. RAL Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
    Table 135. RAL Point-Of-Care Or Rapid Diagnostics Product
    Table 136. RAL Recent Development
    Table 137. Vircell Company Information
    Table 138. Vircell Description and Business Overview
    Table 139. Vircell Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
    Table 140. Vircell Point-Of-Care Or Rapid Diagnostics Product
    Table 141. Vircell Recent Development
    Table 142. Monlab Company Information
    Table 143. Monlab Description and Business Overview
    Table 144. Monlab Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
    Table 145. Monlab Point-Of-Care Or Rapid Diagnostics Product
    Table 146. Monlab Recent Development
    Table 147. Binding Site Company Information
    Table 148. Binding Site Description and Business Overview
    Table 149. Binding Site Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
    Table 150. Binding Site Point-Of-Care Or Rapid Diagnostics Product
    Table 151. Binding Site Recent Development
    Table 152. Key Raw Materials Lists
    Table 153. Raw Materials Key Suppliers Lists
    Table 154. Point-Of-Care Or Rapid Diagnostics Customers List
    Table 155. Point-Of-Care Or Rapid Diagnostics Distributors List
    Table 156. Research Programs/Design for This Report
    Table 157. Key Data Information from Secondary Sources
    Table 158. Key Data Information from Primary Sources
List of Figures
    Figure 1. Point-Of-Care Or Rapid Diagnostics Product Picture
    Figure 2. Global Point-Of-Care Or Rapid Diagnostics Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Point-Of-Care Or Rapid Diagnostics Market Size 2018-2029 (US$ Million)
    Figure 4. Global Point-Of-Care Or Rapid Diagnostics Sales 2018-2029 (K Doses)
    Figure 5. India Point-Of-Care Or Rapid Diagnostics Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 6. India Point-Of-Care Or Rapid Diagnostics Market Size 2018-2029 (US$ Million)
    Figure 7. India Point-Of-Care Or Rapid Diagnostics Sales 2018-2029 (K Doses)
    Figure 8. India Point-Of-Care Or Rapid Diagnostics Market Share in Global, in Value (US$ Million) 2018-2029
    Figure 9. India Point-Of-Care Or Rapid Diagnostics Market Share in Global, in Volume (K Doses) 2018-2029
    Figure 10. Point-Of-Care Or Rapid Diagnostics Report Years Considered
    Figure 11. Product Picture of Intensive Care
    Figure 12. Product Picture of Covid-19 Testing
    Figure 13. Product Picture of Infectious Diseases Testing
    Figure 14. Product Picture of Cardiac Markers Testing
    Figure 15. Product Picture of Coagulation Testing
    Figure 16. Product Picture of Others
    Figure 17. Global Point-Of-Care Or Rapid Diagnostics Market Share by Type in 2022 & 2029
    Figure 18. Global Point-Of-Care Or Rapid Diagnostics Sales in Value by Type (2018-2029) & (US$ Million)
    Figure 19. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share in Value by Type (2018-2029)
    Figure 20. Global Point-Of-Care Or Rapid Diagnostics Sales by Type (2018-2029) & (K Doses)
    Figure 21. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share in Volume by Type (2018-2029)
    Figure 22. Global Point-Of-Care Or Rapid Diagnostics Price by Type (2018-2029) & (US$/Dose)
    Figure 23. India Point-Of-Care Or Rapid Diagnostics Market Share by Type in 2022 & 2029
    Figure 24. India Point-Of-Care Or Rapid Diagnostics Sales in Value by Type (2018-2029) & (US$ Million)
    Figure 25. India Point-Of-Care Or Rapid Diagnostics Sales Market Share in Value by Type (2018-2029)
    Figure 26. India Point-Of-Care Or Rapid Diagnostics Sales by Type (2018-2029) & (K Doses)
    Figure 27. India Point-Of-Care Or Rapid Diagnostics Sales Market Share in Volume by Type (2018-2029)
    Figure 28. India Point-Of-Care Or Rapid Diagnostics Price by Type (2018-2029) & (US$/Dose)
    Figure 29. Product Picture of Hospital
    Figure 30. Product Picture of Clinic
    Figure 31. Product Picture of Independent Laboratories
    Figure 32. Product Picture of Others
    Figure 33. Global Point-Of-Care Or Rapid Diagnostics Market Share by Application in 2022 & 2029
    Figure 34. Global Point-Of-Care Or Rapid Diagnostics Sales in Value by Application (2018-2029) & (US$ Million)
    Figure 35. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share in Value by Application (2018-2029)
    Figure 36. Global Point-Of-Care Or Rapid Diagnostics Sales by Application (2018-2029) & (K Doses)
    Figure 37. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share in Volume by Application (2018-2029)
    Figure 38. Global Point-Of-Care Or Rapid Diagnostics Price by Application (2018-2029) & (US$/Dose)
    Figure 39. India Point-Of-Care Or Rapid Diagnostics Market Share by Application in 2022 & 2029
    Figure 40. India Point-Of-Care Or Rapid Diagnostics Sales in Value by Application (2018-2029) & (US$ Million)
    Figure 41. India Point-Of-Care Or Rapid Diagnostics Sales Market Share in Value by Application (2018-2029)
    Figure 42. India Point-Of-Care Or Rapid Diagnostics Sales by Application (2018-2029) & (K Doses)
    Figure 43. India Point-Of-Care Or Rapid Diagnostics Sales Market Share in Volume by Application (2018-2029)
    Figure 44. India Point-Of-Care Or Rapid Diagnostics Price by Application (2018-2029) & (US$/Dose)
    Figure 45. Americas Point-Of-Care Or Rapid Diagnostics Sales in Volume Growth Rate 2018-2029 (K Doses)
    Figure 46. Americas Point-Of-Care Or Rapid Diagnostics Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 47. Americas Point-Of-Care Or Rapid Diagnostics Sales by Type (2018-2029) & (K Doses)
    Figure 48. Americas Point-Of-Care Or Rapid Diagnostics Sales Market Share in Volume by Type (2018-2029)
    Figure 49. Americas Point-Of-Care Or Rapid Diagnostics Sales by Application (2018-2029) & (K Doses)
    Figure 50. Americas Point-Of-Care Or Rapid Diagnostics Sales Market Share in Volume by Application (2018-2029)
    Figure 51. United States Point-Of-Care Or Rapid Diagnostics Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 52. Canada Point-Of-Care Or Rapid Diagnostics Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 53. Mexico Point-Of-Care Or Rapid Diagnostics Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 54. Brazil Point-Of-Care Or Rapid Diagnostics Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 55. EMEA Point-Of-Care Or Rapid Diagnostics Sales in Volume Growth Rate 2018-2029 (K Doses)
    Figure 56. EMEA Point-Of-Care Or Rapid Diagnostics Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 57. EMEA Point-Of-Care Or Rapid Diagnostics Sales by Type (2018-2029) & (K Doses)
    Figure 58. EMEA Point-Of-Care Or Rapid Diagnostics Sales Market Share in Volume by Type (2018-2029)
    Figure 59. EMEA Point-Of-Care Or Rapid Diagnostics Sales by Application (2018-2029) & (K Doses)
    Figure 60. EMEA Point-Of-Care Or Rapid Diagnostics Sales Market Share in Volume by Application (2018-2029)
    Figure 61. Europe Point-Of-Care Or Rapid Diagnostics Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 62. Middle East Point-Of-Care Or Rapid Diagnostics Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 63. Africa Point-Of-Care Or Rapid Diagnostics Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 64. China Point-Of-Care Or Rapid Diagnostics Sales in Volume Growth Rate 2018-2029 (K Doses)
    Figure 65. China Point-Of-Care Or Rapid Diagnostics Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 66. China Point-Of-Care Or Rapid Diagnostics Sales by Type (2018-2029) & (K Doses)
    Figure 67. China Point-Of-Care Or Rapid Diagnostics Sales Market Share in Volume by Type (2018-2029)
    Figure 68. China Point-Of-Care Or Rapid Diagnostics Sales by Application (2018-2029) & (K Doses)
    Figure 69. China Point-Of-Care Or Rapid Diagnostics Sales Market Share in Volume by Application (2018-2029)
    Figure 70. APAC Point-Of-Care Or Rapid Diagnostics Sales in Volume Growth Rate 2018-2029 (K Doses)
    Figure 71. APAC Point-Of-Care Or Rapid Diagnostics Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 72. APAC Point-Of-Care Or Rapid Diagnostics Sales by Type (2018-2029) & (K Doses)
    Figure 73. APAC Point-Of-Care Or Rapid Diagnostics Sales Market Share in Volume by Type (2018-2029)
    Figure 74. APAC Point-Of-Care Or Rapid Diagnostics Sales by Application (2018-2029) & (K Doses)
    Figure 75. APAC Point-Of-Care Or Rapid Diagnostics Sales Market Share in Volume by Application (2018-2029)
    Figure 76. Japan Point-Of-Care Or Rapid Diagnostics Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 77. South Korea Point-Of-Care Or Rapid Diagnostics Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 78. China Taiwan Point-Of-Care Or Rapid Diagnostics Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 79. Southeast Asia Point-Of-Care Or Rapid Diagnostics Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 80. India Point-Of-Care Or Rapid Diagnostics Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 81. Point-Of-Care Or Rapid Diagnostics Value Chain
    Figure 82. Point-Of-Care Or Rapid Diagnostics Production Process
    Figure 83. Channels of Distribution
    Figure 84. Distributors Profiles
    Figure 85. Bottom-up and Top-down Approaches for This Report
    Figure 86. Data Triangulation
    Figure 87. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4350

This license allows only one user to access the PDF.
Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS